CZ2294A3 - O-aryl ethers of morphinans, their utilization, process of their preparation and pharmaceutical preparations based thereon - Google Patents
O-aryl ethers of morphinans, their utilization, process of their preparation and pharmaceutical preparations based thereon Download PDFInfo
- Publication number
- CZ2294A3 CZ2294A3 CZ9422A CZ2294A CZ2294A3 CZ 2294 A3 CZ2294 A3 CZ 2294A3 CZ 9422 A CZ9422 A CZ 9422A CZ 2294 A CZ2294 A CZ 2294A CZ 2294 A3 CZ2294 A3 CZ 2294A3
- Authority
- CZ
- Czechia
- Prior art keywords
- morphinan
- methyl
- formula
- alkyl
- pyridinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US113593A | 1993-01-06 | 1993-01-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CZ2294A3 true CZ2294A3 (en) | 1994-07-13 |
Family
ID=21694554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ9422A CZ2294A3 (en) | 1993-01-06 | 1994-01-05 | O-aryl ethers of morphinans, their utilization, process of their preparation and pharmaceutical preparations based thereon |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0612730B1 (enExample) |
| JP (1) | JP2501298B2 (enExample) |
| KR (1) | KR940018094A (enExample) |
| CN (1) | CN1097006A (enExample) |
| AT (1) | ATE154931T1 (enExample) |
| AU (1) | AU681601B2 (enExample) |
| BR (1) | BR9400021A (enExample) |
| CA (1) | CA2110337A1 (enExample) |
| CZ (1) | CZ2294A3 (enExample) |
| DE (1) | DE69311887T2 (enExample) |
| DK (1) | DK0612730T3 (enExample) |
| ES (1) | ES2105061T3 (enExample) |
| FI (1) | FI940041L (enExample) |
| GR (1) | GR3024891T3 (enExample) |
| HU (2) | HUT66061A (enExample) |
| IL (1) | IL108247A (enExample) |
| MX (1) | MX9400177A (enExample) |
| NO (1) | NO940028D0 (enExample) |
| NZ (1) | NZ250580A (enExample) |
| PL (1) | PL175365B1 (enExample) |
| TW (1) | TW264473B (enExample) |
| UY (1) | UY23706A1 (enExample) |
| ZA (1) | ZA939806B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9522176D0 (en) * | 1995-10-30 | 1996-01-03 | Iaf Biochem Int | Morphinan derivatives having neuroprotective activity |
| EP1384720A1 (en) * | 1996-06-13 | 2004-01-28 | SUMIKA FINE CHEMICALS Co., Ltd. | Process for drying paroxetine hydrochloride |
| FR2752163B1 (fr) * | 1996-08-12 | 1998-10-30 | Pf Medicament | Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington |
| GB9706753D0 (en) * | 1997-04-03 | 1997-05-21 | Pharmacia & Upjohn Spa | Aralkoxy-morphinan derivatives |
| KR100425881B1 (ko) * | 2001-03-14 | 2004-04-03 | 고광호 | 신규한 몰피난 유도체 |
| WO2003097608A2 (en) * | 2002-05-17 | 2003-11-27 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| DE10229842A1 (de) * | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
| US20040204862A1 (en) * | 2003-04-11 | 2004-10-14 | Wainer Irving W. | Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| JP5784507B2 (ja) * | 2009-02-23 | 2015-09-24 | マリンクロッド エルエルシー | （＋）−モルフィナニウム第四級塩およびその生成方法 |
| CN103044327B (zh) * | 2013-01-07 | 2014-12-17 | 苏州立新制药有限公司 | 一种右美沙芬的制备方法 |
| US20190111047A1 (en) * | 2014-09-14 | 2019-04-18 | Avanir Pharmaceuticals, Inc. | Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementia |
| US20160243112A1 (en) * | 2015-02-25 | 2016-08-25 | Alkermes, Inc. | Treatments for alzheimer's related diseases and disorders |
| EP4206203A4 (en) * | 2020-08-28 | 2024-12-11 | Nippon Chemiphar Co., Ltd. | PROCESS FOR PREPARING A MORPHINAN DERIVATIVE WITH A MAIN CHAIN FORMED FROM DIARYL ETHER USING A NOVEL COPPER CATALYST |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI773636A7 (fi) * | 1976-12-06 | 1978-06-07 | Hoffmann La Roche | Nya fenylderivat |
| US4113729A (en) * | 1976-12-06 | 1978-09-12 | Hoffmann-La Roche Inc. | 3-Phenoxymorphinans and derivatives thereof |
| US4806543A (en) * | 1986-11-25 | 1989-02-21 | Board Of Trustees Of The Leland Stanford Junior University | Method and compositions for reducing neurotoxic injury |
-
1993
- 1993-11-25 TW TW082109942A patent/TW264473B/zh active
- 1993-11-30 CA CA002110337A patent/CA2110337A1/en not_active Abandoned
- 1993-12-20 EP EP93120498A patent/EP0612730B1/en not_active Expired - Lifetime
- 1993-12-20 DE DE69311887T patent/DE69311887T2/de not_active Expired - Fee Related
- 1993-12-20 ES ES93120498T patent/ES2105061T3/es not_active Expired - Lifetime
- 1993-12-20 DK DK93120498.6T patent/DK0612730T3/da active
- 1993-12-20 AT AT93120498T patent/ATE154931T1/de not_active IP Right Cessation
- 1993-12-23 NZ NZ250580A patent/NZ250580A/en unknown
- 1993-12-30 JP JP5354172A patent/JP2501298B2/ja not_active Expired - Lifetime
- 1993-12-30 ZA ZA939806A patent/ZA939806B/xx unknown
- 1993-12-31 UY UY23706A patent/UY23706A1/es unknown
- 1993-12-31 AU AU52807/93A patent/AU681601B2/en not_active Ceased
- 1993-12-31 IL IL108247A patent/IL108247A/en not_active IP Right Cessation
-
1994
- 1994-01-03 HU HU9400002A patent/HUT66061A/hu unknown
- 1994-01-03 MX MX9400177A patent/MX9400177A/es not_active IP Right Cessation
- 1994-01-04 NO NO940028A patent/NO940028D0/no unknown
- 1994-01-04 KR KR1019940000067A patent/KR940018094A/ko not_active Ceased
- 1994-01-05 CN CN94100181A patent/CN1097006A/zh active Pending
- 1994-01-05 FI FI940041A patent/FI940041L/fi unknown
- 1994-01-05 PL PL94301784A patent/PL175365B1/pl unknown
- 1994-01-05 BR BR9400021A patent/BR9400021A/pt not_active Application Discontinuation
- 1994-01-05 CZ CZ9422A patent/CZ2294A3/cs unknown
-
1995
- 1995-06-19 HU HU95P/P00253P patent/HU211290A9/hu unknown
-
1997
- 1997-09-30 GR GR970402538T patent/GR3024891T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL108247A (en) | 1998-02-22 |
| HU211290A9 (en) | 1995-11-28 |
| CN1097006A (zh) | 1995-01-04 |
| UY23706A1 (es) | 1994-06-05 |
| ES2105061T3 (es) | 1997-10-16 |
| NO940028D0 (no) | 1994-01-04 |
| GR3024891T3 (en) | 1998-01-30 |
| PL301784A1 (en) | 1994-07-11 |
| PL175365B1 (pl) | 1998-12-31 |
| AU681601B2 (en) | 1997-09-04 |
| HU9400002D0 (en) | 1994-05-30 |
| MX9400177A (es) | 1994-07-29 |
| EP0612730A1 (en) | 1994-08-31 |
| TW264473B (enExample) | 1995-12-01 |
| DE69311887D1 (de) | 1997-08-07 |
| ZA939806B (en) | 1994-07-06 |
| BR9400021A (pt) | 1994-07-26 |
| JP2501298B2 (ja) | 1996-05-29 |
| FI940041A0 (fi) | 1994-01-05 |
| DE69311887T2 (de) | 1998-01-15 |
| JPH06316564A (ja) | 1994-11-15 |
| HUT66061A (en) | 1994-09-28 |
| KR940018094A (ko) | 1994-08-16 |
| FI940041A7 (fi) | 1994-07-07 |
| FI940041L (fi) | 1994-07-07 |
| AU5280793A (en) | 1994-07-14 |
| CA2110337A1 (en) | 1994-07-07 |
| DK0612730T3 (da) | 1998-02-02 |
| ATE154931T1 (de) | 1997-07-15 |
| NO940028L (enExample) | 1994-07-07 |
| EP0612730B1 (en) | 1997-07-02 |
| IL108247A0 (en) | 1994-04-12 |
| NZ250580A (en) | 1996-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2762680C (en) | Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics | |
| CA2888210C (en) | Methylene linked quinolinyl modulators of ror-gamma-t | |
| JP6193848B2 (ja) | 複素環化合物及びその用途 | |
| UA55461C2 (uk) | 2-амінопіридини, які мають циклоконденсовані замісники, як інгібітори оксиду азоту синтази, фармацевтичні композиції, способи лікування або попередження хворобливих станів та спосіб інгібування оксиду азоту синтази | |
| CZ201799A3 (cs) | 6-Fenylpyridin-2-ylaminové deriváty, farmaceutické kompozice na jejich bázi a způsoby léčení | |
| WO2001007411A1 (en) | Biarylurea derivatives | |
| CZ2294A3 (en) | O-aryl ethers of morphinans, their utilization, process of their preparation and pharmaceutical preparations based thereon | |
| CS414391A3 (en) | Benzo(5,6)cycloheptapyridines, preparations and methods of use | |
| SK113998A3 (en) | 6-phenylpyridyl-2-amine derivatives | |
| MX2008008339A (es) | Derivados de anilina sustituida ùtiles como antagonistas de la histamina h3. | |
| US6399636B2 (en) | Tri-aryl-substituted-ethane PDE4 inhibitors | |
| TW201934551A (zh) | 製造生長抑制素調節劑之方法 | |
| JP5355551B2 (ja) | キノロン化合物及び医薬組成物 | |
| JP2889056B2 (ja) | メタノアントラセン化合物、該化合物を含有する精神病治療用医薬調剤および上記化合物の製造方法ならびに中間体 | |
| EP3700895B1 (en) | Polycyclic amides as muscarinic m1 receptor positive allosteric modulators | |
| KR20220052333A (ko) | 근위축성 측색 경화증 및 관련 장애의 치료를 위한 tdp-43에 결합하는 분자 | |
| US5512575A (en) | Methanoanthraceneyl methyl piperidinyl compounds | |
| IL273748A (en) | Troueryl compounds as positive allosteric modulators for muscarinic m1 receptors | |
| KR20000070756A (ko) | 동맥경화증 및 지단백질과잉혈증 치료에 사용되는 2-아미노 치환된 피리딘 | |
| US5849765A (en) | Tetrahydropyridine derivatives as dopamine receptor subtype ligands | |
| EP1848696A1 (en) | Imidazole and benzimidazole derivates useful as histamine h3 antagonists | |
| JP5769504B2 (ja) | 医薬 | |
| SK17122002A3 (sk) | Derivát heterocyklického aminoalkylpyridínu ako psychofarmaceutické činidlo, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje | |
| JP2018203793A (ja) | 医薬 | |
| RU2123000C1 (ru) | О-арильные эфиры морфинанов, фармацевтическая композиция |